Cost-Effectiveness of ramucirumab plus paclitaxel as a second-line therapy for advanced gastric or gastro-oesophageal cancer in China

• Sini Li,

  Roles Formal analysis, Project administration, Writing – original draft

  Affiliation The Xiangya Nursing School, Central South University, Changsha, Hunan, China

  http://orcid.org/0000-0002-1347-4024

  ⨯
• Liubao Peng,

  Roles Conceptualization, Supervision

  Affiliation Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Chongqing Tan,

  Roles Data curation, Project administration

  Affiliation Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Xiaohui Zeng,

  Roles Methodology, Software

  Affiliation The Second Xiangya Hospital, PET-CT Center, Central South University, Changsha, Hunan, China

  ⨯
• Xiaomin Wan,

  Roles Methodology, Software

  Affiliation The Xiangya Nursing School, Central South University, Changsha, Hunan, China

  ⨯
• Xia Luo,

  Roles Validation, Visualization

  Affiliation Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Lidan Yi,

  Roles Data curation

  Affiliation Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯
• Jianhe Li

  Roles Supervision, Writing – review & editing

  * E-mail: lijianhexy@126.com

  Affiliation Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China

  ⨯